Literature DB >> 3565107

An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.

M Gossop, B Bradley, G T Phillips.   

Abstract

Methadone detoxification procedures are widely accepted as a satisfactory way of withdrawing opiate addicts from drugs. There have, however, been comparatively few empirical studies which have examined the development and course of withdrawal symptoms in opiate addicts in response to such detoxification procedures. This study investigates the opiate withdrawal syndrome in a group of 116 opiate addicts during and subsequent to a gradual oral methadone detoxification programme. Withdrawal symptoms peak at the end of the methadone schedule and decline steadily thereafter. Not until 40 days after the beginning of the withdrawal regime have symptom levels returned to normal. It is suggested that this protracted withdrawal response is not entirely satisfactory and alternative clinical and research options are proposed. The results fail to support the accepted view that dose is a major determinant of withdrawal severity. Low dose users did not experience less severe withdrawal symptoms than high dose users. This finding together with those of a previous study suggest that this issue also warrants further research attention.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3565107     DOI: 10.1016/0306-4603(87)90002-5

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  13 in total

1.  Transitioning opioid-dependent patients from detoxification to long-term treatment: efficacy of intensive role induction.

Authors:  Elizabeth C Katz; Barry S Brown; Robert P Schwartz; Kevin E O'Grady; Stuart D King; Devang Gandhi
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

2.  Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine.

Authors:  Andrew J Waters; Reshmi Marhe; Ingmar H A Franken
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 3.  Update on the clinical use of buprenorphine: in opioid-related disorders.

Authors:  Simon Ducharme; Ronald Fraser; Kathryn Gill
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

4.  [The drug addict in prison: Medical response and its limitations].

Authors:  R Jeanmonod; T Harding
Journal:  Soz Praventivmed       Date:  1988

5.  Prison: shield from threat, or threat to survival?

Authors:  M Ross; A B Grossman; S Murdoch; R Bundey; J Golding; S Purchase; T Munyard; M Scott; A Bridger
Journal:  BMJ       Date:  1994-04-23

Review 6.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats.

Authors:  Jin-Long Gao; Shao-Ang Tu; Jia Liu; Jin-Ming Zhang; Yiyun Huang; Mei Han; Jian-Hui Liang
Journal:  BMC Complement Altern Med       Date:  2014-08-19       Impact factor: 3.659

8.  The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study.

Authors:  Tea Rosic; Leen Naji; Monica Bawor; Brittany B Dennis; Carolyn Plater; David C Marsh; Lehana Thabane; Zainab Samaan
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-24       Impact factor: 2.570

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.

Authors:  Ekkehard Madlung-Kratzer; Bernhard Spitzer; Berhard Spitzer; Renate Brosch; Dirk Dunkel; Christian Haring
Journal:  Addiction       Date:  2009-09       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.